BioSpace News Archive

Phoenix PharmaLabs has been awarded a $2.7 million grant from the Department of Defense/US Army Medical Research Acquisition Activity.

Evaluate Ltd. releases annual “EvaluateMedtech World Preview 2018, Outlook to 2024” in conjunction with The Medtech Conference

Zynex, Inc. today announced that Thomas Sandgaard, Chief Executive Officer of Zynex, will be presenting at the Ladenburg Thalmann 2018 Healthcare Conference, on Tuesday October 2, 2018 at 2:30 pm EDT.

Asteres Inc. announced today that Governor Jerry Brown signed SB1447 for the expanded use of Automated Patient Delivery Systems (APDS) in California.

Patients who switched to newer IL-17 biologics reported improved outcomes

AirXpanders, Inc., announced a series of activities at the American Society of Plastic Surgeons’ (ASPS) Plastic Surgery The Meeting in Chicago.

Horizon Pharma plc (NASDAQ: HZNP) will present new data on the 48-week follow up for the Phase 2 clinical trial evaluating teprotumumab for the treatment of moderate-to-severe active thyroid eye disease (TED)

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of IMFINZI® (durvalumab) during the Presidential Symposium of the IASLC 19th World Conference on Lung Cancer hosted by the International Association for the Study of Lung Cancer in Toronto, Canada

ForeverGreen(TM) Worldwide Corporation (OTCQB: FVRG), a global direct marketing company and provider of health and wellness products, announces the European Registration for the KetonX Weight Loss System. KetonX is quickly becoming one of the top, leading products at ForeverGreen.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced that live demonstrations of the Pulse™ surgical automation platform with integration of the Siemens Healthineers’ Cios Spin* cutting-edge mobile 3D-imaging will be held throughout the North American Spine Society (NASS) 2018 Annual Meeting, September 26-29, 2018.